These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 857368)
1. [Pelvic lymphadenectomy as a staging operation for prostate carcinome (author's transl)]. Kurth tkh ; Altwein JE; Hohenfellner R Urologe A; 1977 Mar; 16(2):65-9. PubMed ID: 857368 [TBL] [Abstract][Full Text] [Related]
2. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. Heidenreich A; Varga Z; Von Knobloch R J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387 [TBL] [Abstract][Full Text] [Related]
3. [Staging pelvic lymphadenectomy for carcinoma of the prostate]. Rinsho K; Ishikawa S; Nemoto R; Koiso K; Takeshima H; Uchida K Hinyokika Kiyo; 1985 Sep; 31(9):1583-7. PubMed ID: 4083215 [TBL] [Abstract][Full Text] [Related]
4. Value of and indications for pelvic lymph node dissection in the staging of prostate cancer. Middleton RG NCI Monogr; 1988; (7):41-3. PubMed ID: 3173502 [TBL] [Abstract][Full Text] [Related]
5. Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect 5-year failure rates for low, intermediate and high risk prostate cancer: results from CaPSURE. Berglund RK; Sadetsky N; DuChane J; Carroll PR; Klein EA J Urol; 2007 Feb; 177(2):526-29; discussion 529-30. PubMed ID: 17222625 [TBL] [Abstract][Full Text] [Related]
6. Is pelvic lymphadenectomy really necessary in patients with a serum prostate-specific antigen level of <10 ng/ml undergoing radical prostatectomy for prostate cancer? Burkhard FC; Schumacher M; Thalmann GN; Studer UE BJU Int; 2005 Feb; 95(3):275-8. PubMed ID: 15679776 [No Abstract] [Full Text] [Related]
8. [Clinical outcome of radical prostatectomy and pelvic lymph node dissection]. Mizutani K; Ono Y; Kato N; Takeda A; Yamada S; Kinukawa T; Hattori R; Sahashi M; Matsuura O; Takeuchi N Hinyokika Kiyo; 1995 Nov; 41(11):867-71. PubMed ID: 8533688 [TBL] [Abstract][Full Text] [Related]
9. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer]. Heidenreich A; Ohlmann CH Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337 [TBL] [Abstract][Full Text] [Related]
13. A new minimally invasive open pelvic lymphadenectomy surgical technique for the staging of prostate cancer. Brant LA; Brant WO; Brown MH; Seid DL; Allen RE Urology; 1996 Mar; 47(3):416-21. PubMed ID: 8633413 [TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184 [TBL] [Abstract][Full Text] [Related]
15. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy. Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707 [TBL] [Abstract][Full Text] [Related]